Literature DB >> 21958843

Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjects.

Crystal K Tjhia1, Clarita V Odvina, D Sudhaker Rao, Susan M Stover, Xiang Wang, David P Fyhrie.   

Abstract

Pathogenesis of atypical fractures in patients on long term bisphosphonate therapy is poorly understood, and the type, the manner in which they occur and the fracture sites are quite different from the usual osteoporotic fractures. We hypothesized that the tissue-level mechanical properties and mean degree of mineralization of the iliac bone would differ among 1) patients with atypical fractures and severely suppressed bone turnover (SSBT) associated with long-term bisphosphonate therapy, 2) age-matched, treatment-naïve osteoporotic patients with vertebral fracture, 3) age-matched normals and 4) young normals. Large differences in tissue-level mechanical properties and/or mineralization among these groups could help explain the underlying mechanism(s) for the occurrence of typical osteoporotic and the atypical femoral shaft fractures. Elastic modulus, contact hardness, plastic deformation resistance, and tissue mineral densities of cortical and trabecular bone regions of 55 iliac bone biopsies--12 SSBT patients (SSBT; aged 49-77), 11 age-matched untreated osteoporotic patients with vertebral fracture (Osteoporotic), 12 age-matched subjects without bone fracture (Age-Matched Normal), and 20 younger subjects without bone fracture (Young Normal)--were measured using nanoindentation and quantitative backscattered electron microscopy. For cortical bone nanoindentation properties, only plastic deformation resistance was different among the groups (p<0.05), with greater resistance to plastic deformation in the SSBT group compared to all other groups. For trabecular bone, all nanoindentation properties and mineral density of the trabecular bone were different among the groups (p<0.05). The SSBT group had greater plastic deformation resistance and harder trabecular bone compared to the other three groups, stiffer bone compared to the Osteoporotic and Young Normal groups, and a trend of higher mineral density compared to the Age-Matched Normal and Osteoporotic groups. Lower heterogeneity of modulus and contact hardness for cortical bone of the SSBT and trabecular bone of the Osteoporotic fracture groups, respectively, compared to the non-fractured groups, may contribute to fracture susceptibility due to lowered ability to prevent crack propagation. We tentatively conclude that, in addition to extremely low bone formation rate, atypical fractures in SSBT and/or long-term bisphosphonate treatment may be associated with greater mean plastic deformation resistance properties and less heterogeneous elastic properties of the bone. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21958843      PMCID: PMC3221814          DOI: 10.1016/j.bone.2011.09.042

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  45 in total

1.  Low bone turnover and microdamage? How and where to assess it?

Authors:  David B Burr; Matthew R Allen
Journal:  J Bone Miner Res       Date:  2008-07       Impact factor: 6.741

2.  Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate.

Authors:  Brett A Lenart; Dean G Lorich; Joseph M Lane
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

3.  Bone fracture: When the cracks begin to show.

Authors:  Peter Fratzl
Journal:  Nat Mater       Date:  2008-08       Impact factor: 43.841

Review 4.  Bone microdamage and skeletal fragility in osteoporotic and stress fractures.

Authors:  D B Burr; M R Forwood; D P Fyhrie; R B Martin; M B Schaffler; C H Turner
Journal:  J Bone Miner Res       Date:  1997-01       Impact factor: 6.741

5.  Spectroscopic markers of bone quality in alendronate-treated postmenopausal women.

Authors:  A L Boskey; L Spevak; R S Weinstein
Journal:  Osteoporos Int       Date:  2008-09-04       Impact factor: 4.507

6.  Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis.

Authors:  Jan J Stepan; David B Burr; Imre Pavo; Adrien Sipos; Dana Michalska; Jiliang Li; Astrid Fahrleitner-Pammer; Helmut Petto; Michael Westmore; David Michalsky; Masahiko Sato; Harald Dobnig
Journal:  Bone       Date:  2007-05-18       Impact factor: 4.398

7.  Identification of material parameters based on Mohr-Coulomb failure criterion for bisphosphonate treated canine vertebral cancellous bone.

Authors:  Xiang Wang; Matthew R Allen; David B Burr; Enrique J Lavernia; Boris Jeremić; David P Fyhrie
Journal:  Bone       Date:  2008-06-10       Impact factor: 4.398

8.  Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment.

Authors:  Matthew R Allen; Susan Reinwald; David B Burr
Journal:  Calcif Tissue Int       Date:  2008-05-08       Impact factor: 4.333

9.  Cancellous bone lamellae strongly affect microcrack propagation and apparent mechanical properties: separation of patients with osteoporotic fracture from normal controls using a 2D nonlinear finite element method (biomechanical stereology).

Authors:  Xiang Wang; Roger R Zauel; D Sudhaker Rao; David P Fyhrie
Journal:  Bone       Date:  2008-02-15       Impact factor: 4.398

10.  Human iliac crest cancellous bone elastic modulus and hardness differ with bone formation rate per bone surface but not by existence of prevalent vertebral fracture.

Authors:  Xiang Wang; D Sudhaker Rao; Leonardo Ajdelsztajn; Traci E Ciarelli; Enrique J Lavernia; David P Fyhrie
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2008-04       Impact factor: 3.368

View more
  24 in total

Review 1.  Atypical femoral fractures: epidemiology, etiology, and patient management.

Authors:  Eve Donnelly; Anas Saleh; Aasis Unnanuntana; Joseph M Lane
Journal:  Curr Opin Support Palliat Care       Date:  2012-09       Impact factor: 2.302

2.  Sexually Dimorphic Influence of Neonatal Antibiotics on Bone.

Authors:  Matteo M Pusceddu; Patricia J Stokes; Alice Wong; Melanie G Gareau; Damian C Genetos
Journal:  J Orthop Res       Date:  2019-07-26       Impact factor: 3.494

Review 3.  Measuring bone quality.

Authors:  Elisa Torres-del-Pliego; Laia Vilaplana; Roberto Güerri-Fernández; Adolfo Diez-Pérez
Journal:  Curr Rheumatol Rep       Date:  2013-11       Impact factor: 4.592

Review 4.  Anabolic agents: what is beyond osteoporosis?

Authors:  Y Liu; A E Levack; E Marty; O Or; B P Samuels; M Redko; J M Lane
Journal:  Osteoporos Int       Date:  2018-04-07       Impact factor: 4.507

Review 5.  Bone mineralization: from tissue to crystal in normal and pathological contexts.

Authors:  Y Bala; D Farlay; G Boivin
Journal:  Osteoporos Int       Date:  2012-12-11       Impact factor: 4.507

6.  Intrinsic material property differences in bone tissue from patients suffering low-trauma osteoporotic fractures, compared to matched non-fracturing women.

Authors:  S Vennin; A Desyatova; J A Turner; P A Watson; J M Lappe; R R Recker; M P Akhter
Journal:  Bone       Date:  2017-01-27       Impact factor: 4.398

Review 7.  Multiscale contribution of bone tissue material property heterogeneity to trabecular bone mechanical behavior.

Authors:  Ashley A Lloyd; Zhen Xiang Wang; Eve Donnelly
Journal:  J Biomech Eng       Date:  2015-01       Impact factor: 2.097

8.  Moderate chronic kidney disease impairs bone quality in C57Bl/6J mice.

Authors:  Chelsea M Heveran; Alicia M Ortega; Andrew Cureton; Ryan Clark; Eric W Livingston; Ted A Bateman; Moshe Levi; Karen B King; Virginia L Ferguson
Journal:  Bone       Date:  2016-02-06       Impact factor: 4.398

Review 9.  Atypical femoral fractures: a review of the literature.

Authors:  Pingal A Desai; Parth A Vyas; Joseph M Lane
Journal:  Curr Osteoporos Rep       Date:  2013-09       Impact factor: 5.096

Review 10.  Tissue-Level Mechanical Properties of Bone Contributing to Fracture Risk.

Authors:  Jeffry S Nyman; Mathilde Granke; Robert C Singleton; George M Pharr
Journal:  Curr Osteoporos Rep       Date:  2016-08       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.